Cartesian Therapeutics, Inc.

Historical 13F Holders

Symbol
RNAC
CUSIP
816212302
All holders as of
Q1 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 73 6.58 M $86.7 M
2024 Q4 69 6.67 M $119 M
2024 Q3 66 7.18 M $115 M
2024 Q2 67 3.68 M $99.2 M
2024 Q1 4 1.86 k $1.16 k
2023 Q3 1 1.20 k $1.27 k
2023 Q2 1 1.20 k $1.34 k
2023 Q1 1 1.20 k $1.67 k